M. Fitzgerald Joseph's most recent trade in Boston Scientific Corp. was a trade of 50,000 Common Stock done at an average price of $26.2 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Jul 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 50,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 106.97 per share. | 01 Jul 2025 | 50,000 | 178,342 (0%) | 0% | 107.0 | 5,348,315 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 04 Jun 2025 | 56,372 | 178,342 (0%) | 0% | 102.9 | 5,799,630 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 04 Jun 2025 | 56,372 | 234,714 (0%) | 0% | 26.2 | 1,474,128 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 56,372 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 1,700 | 178,682 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 5,234 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 178,342 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Feb 2025 | 1,000 | 180,382 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 28,789 | 28,789 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,188 | 11,188 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 179,108 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 8,725 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 183,439 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 181,078 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 3,960 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 2,057 | 181,382 (0%) | 0% | 106.1 | 218,268 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,990 | 177,118 (0%) | 0% | 106.1 | 211,159 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,806 | 179,272 (0%) | 0% | 106.1 | 191,635 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 176,325 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 10,386 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 1,579 | 174,746 (0%) | 0% | 105.8 | 167,011 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 162,025 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 0 | - | - | Performance Share Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 6,425 | 155,600 (0%) | 0% | 89.3 | 573,881 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2024 | 31,680 | 187,310 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 03 Dec 2024 | 14,447 | 172,863 (0%) | 0% | 106.0 | 1,531,093 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Purchase of securities on an exchange or from another person at price $ 90.30 per share. | 03 Dec 2024 | 50 | 148,168 (0%) | 0% | 90.3 | 4,515 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 89.95 per share. | 03 Dec 2024 | 20 | 148,148 (0%) | 0% | 90.0 | 1,799 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 11,236 | 148,118 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 1,113 | 159,354 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 07 Oct 2024 | 132,527 | 160,467 (0%) | 0% | 85.0 | 11,264,888 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 07 Oct 2024 | 59,021 | 235,376 (0%) | 0% | 17.3 | 1,018,702 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 59,021 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 57,618 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.98 per share. | 07 Oct 2024 | 57,618 | 292,994 (0%) | 0% | 25.0 | 1,439,298 | Common Stock |
| Chain Bridge Bancorp Inc. ... | Joseph Fitzgerald Michael | Director | Purchase of securities on an exchange or from another person at price $ 22.00 per share. | 03 Oct 2024 | 1,252 | 1,252 | - | 22 | 27,544 | Class A Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 28 Aug 2024 | 14,132 | 176,355 (0%) | 0% | 80 | 1,130,560 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 13 May 2024 | 2,380 | 190,487 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | 20 Feb 2024 | 67,974 | 0 (0%) | 0% | 66.2 | 4,501,238 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 4,167 | 4,167 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 4,167 | 193,047 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,960 | 190,686 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,960 | 7,920 | - | - | Restricted Stock Units | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,706 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | M. Joseph Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,706 | 194,696 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Fitzgerald Joseph M. | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 2,057 | 190,990 (0%) | 0% | 65.8 | 135,392 | Common Stock |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,829 | 192,867 (0%) | 0% | 65.8 | 120,385 | Common Stock |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,806 | 188,880 (0%) | 0% | 65.8 | 118,871 | Common Stock |
| Boston Scientific | Joseph Fitzgerald M. | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 4,362 | 13,087 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph Fitzgerald M. | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 4,362 | 188,716 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.95 per share. | 14 Feb 2024 | 1,990 | 186,726 (0%) | 0% | 66.0 | 131,241 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 33,332 | 206,804 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Feb 2024 | 16,450 | 190,354 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Joseph Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 12 Jan 2024 | 11,660 | 173,472 (0%) | 0% | 60 | 699,600 | Common Stock |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 29 Dec 2023 | 81,940 | 174,241 (0%) | 0% | 57.5 | 4,711,550 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 29 Dec 2023 | 58,189 | 256,181 (0%) | 0% | 16.3 | 949,063 | Common Stock |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 58,189 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 21,799 | 0 | - | - | Performance Share Units | |
| Boston Scientific | Fitzgerald Joseph M. | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 21,799 | 196,040 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Joseph Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.81 per share. | 29 Dec 2023 | 10,908 | 185,132 (0%) | 0% | 57.8 | 630,591 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 20 Sep 2023 | 15,867 | 197,992 (0%) | 0% | 55 | 872,685 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 53.60 per share. | 16 May 2023 | 63,339 | 213,859 (0%) | 0% | 53.6 | 3,394,856 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 56,921 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.08 per share. | 16 May 2023 | 56,921 | 277,198 (0%) | 0% | 13.1 | 744,527 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,895 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 3,895 | 222,200 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.23 per share. | 21 Feb 2023 | 1,923 | 220,277 (0%) | 0% | 46.2 | 88,900 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 4,166 | 218,484 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 4,166 | 8,334 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,960 | 11,880 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,960 | 216,124 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,706 | 220,134 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2023 | 3,706 | 3,706 | - | - | Deferred Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.54 per share. | 16 Feb 2023 | 2,056 | 216,428 (0%) | 0% | 46.5 | 95,686 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.54 per share. | 16 Feb 2023 | 1,829 | 218,305 (0%) | 0% | 46.5 | 85,122 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.48 per share. | 16 Feb 2023 | 1,806 | 214,318 (0%) | 0% | 46.5 | 83,943 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.29 per share. | 15 Feb 2023 | 2,278 | 212,164 (0%) | 0% | 47.3 | 107,727 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 45,404 | 45,404 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 17,449 | 17,449 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 13,907 | 13,907 | - | - | Performance Share Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2023 | 11,000 | 209,827 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2023 | 2,520 | 220,827 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2023 | 630 | 4,344 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 13,134 | 0 | - | - | Performance Share Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 13,134 | 230,005 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.27 per share. | 01 Jan 2023 | 6,658 | 223,347 (0%) | 0% | 46.3 | 308,066 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.39 per share. | 13 Dec 2022 | 79,264 | 296,135 (0%) | 0% | 7.4 | 585,761 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 47.78 per share. | 13 Dec 2022 | 79,264 | 216,871 (0%) | 0% | 47.8 | 3,787,234 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 79,264 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2022 | 1,000 | 216,871 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2022 | 3,603 | 219,650 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2022 | 3,603 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.96 per share. | 03 Mar 2022 | 1,779 | 217,871 (0%) | 0% | 44.0 | 78,205 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 21,799 | 21,799 | - | - | Performance Share Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 3,895 | 3,895 | - | - | Deferred Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 3,895 | 217,970 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 21 Feb 2022 | 1,923 | 216,047 (0%) | 0% | 42.6 | 81,824 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 4,166 | 214,254 (0%) | 0% | 0 | Common Stock |